Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Anesthetic management of a parturient with neuromyelitis optica.
Spasticity: pathophysiology, evaluation and management.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Cerebral venous sinus thrombosis in the patient with multiple sclerosis associated with congenital antithrombin deficiency.
Tysabri screening test may be unreliable
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Averting inflammation by targeting the cytokine environment.
TH17 cell differentiation is regulated by the circadian clock.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Review: the role of vitamin D in nervous system health and disease.
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Tysabri (natalizumab)
Functional identification of neural stem cell-derived oligodendrocytes.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Merck KGaA to try again to get approval for MS pill cladribine
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »